Medication info
Gyeongbora Rabeprazole Tablet 20 mg (Rabeprazole Sodium)

Gyeongbora Rabeprazole Tablet 20 mg (Rabeprazole Sodium)

Prescription medicationTabletOral
Ingredient · strength
Rabeprazole Sodium›20mg / 1 tablet
Manufacturer / importer
Gyeongbo Pharmaceutical Co., Ltd.
Appearance
Pale yellow, round, enteric-coated tablet
Packaging
28 tablets (14 tablets/AluAlu packaging x 2)
Approval status
Active

MFDS item code 201308942 · Approved 2013.08.22 · Insurance code 665001780

Summary

Main use
Treatment of gastroesophageal reflux disease, peptic ulcers (including in combination with eradication therapy), and Zollinger-Ellison syndrome
Who takes it
Adults · Children
Adult dose
Gastric ulcer, duodenal ulcer: The usual adult dose is 10 mg of rabeprazole sodium orally once daily. Depending on symptoms, 20 mg may be taken orally once daily. Treatment is generally given for up to 8 weeks for gastric ulcers and up to 6 weeks for duodenal ulcers. Erosive or ulcerative gastroesophageal reflux disease: Administer 10 mg or 20 mg once daily for 4 ∼ 8 weeks. If healing has not occurred after 8 weeks of proton pump inhibitor (PPI) treatment, an additional 8 weeks of 10 mg or 20 mg orally twice daily may be given. However, the 20 mg twice-daily regimen is for patients with confirmed severe mucosal damage only. Relief of symptoms of gastroesophageal reflux disease: Administer 10 mg once daily. If symptoms are not controlled after 4 weeks of treatment, further evaluation is required. After symptoms have resolved, subsequent symptoms may be controlled using on-demand therapy with 10 mg once daily as needed. Long-term maintenance treatment of gastroesophageal reflux disease: Administer 10 mg or 20 mg orally once daily, depending on the patient. Helicobacter pylori eradication: Patients with Helicobacter pylori infection should receive eradication therapy. It is recommended to administer this medicine 20 mg with clarithromycin 500 mg and amoxicillin 1 g twice daily for 7 days. Zollinger-Ellison syndrome: The recommended initial adult dose is 60 mg once daily. The dose may be adjusted according to each patient's needs, up to 120 mg daily. Doses up to 100 mg may be administered once daily; the 120 mg dose should be divided into 60 mg twice daily. Patients with Zollinger-Ellison syndrome have received this medicine for up to 1 year.
Child dose
Safety in children has not been established.

Ingredients

Manufacturer
Gyeongbo Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of gastroesophageal reflux disease, peptic ulcers (including in combination with eradication therapy), and Zollinger-Ellison syndrome

  • Gastric ulcers
  • duodenal ulcers
  • erosive gastroesophageal reflux disease
  • ulcerative gastroesophageal reflux disease
  • symptoms of gastroesophageal reflux disease
  • gastrointestinal ulcers
  • Zollinger-Ellison syndrome
View approved original text

This medication is used to treat gastric ulcers, duodenal ulcers, erosive and ulcerative gastroesophageal reflux disease. It alleviates the symptoms of gastroesophageal reflux disease and is also helpful for long-term maintenance therapy for this condition. Additionally, it can be used with antibiotics for patients with gastrointestinal ulcers infected with Helicobacter pylori to enhance therapeutic effects. It is also indicated for the treatment of Zollinger-Ellison syndrome. Therefore, it is used as an effective agent for various gastrointestinal diseases.

How to take

Adult dose

Gastric ulcer, duodenal ulcer: The usual adult dose is 10 mg of rabeprazole sodium orally once daily. Depending on symptoms, 20 mg may be taken orally once daily. Treatment is generally given for up to 8 weeks for gastric ulcers and up to 6 weeks for duodenal ulcers. Erosive or ulcerative gastroesophageal reflux disease: Administer 10 mg or 20 mg once daily for 4 ∼ 8 weeks. If healing has not occurred after 8 weeks of proton pump inhibitor (PPI) treatment, an additional 8 weeks of 10 mg or 20 mg orally twice daily may be given. However, the 20 mg twice-daily regimen is for patients with confirmed severe mucosal damage only. Relief of symptoms of gastroesophageal reflux disease: Administer 10 mg once daily. If symptoms are not controlled after 4 weeks of treatment, further evaluation is required. After symptoms have resolved, subsequent symptoms may be controlled using on-demand therapy with 10 mg once daily as needed. Long-term maintenance treatment of gastroesophageal reflux disease: Administer 10 mg or 20 mg orally once daily, depending on the patient. Helicobacter pylori eradication: Patients with Helicobacter pylori infection should receive eradication therapy. It is recommended to administer this medicine 20 mg with clarithromycin 500 mg and amoxicillin 1 g twice daily for 7 days. Zollinger-Ellison syndrome: The recommended initial adult dose is 60 mg once daily. The dose may be adjusted according to each patient's needs, up to 120 mg daily. Doses up to 100 mg may be administered once daily; the 120 mg dose should be divided into 60 mg twice daily. Patients with Zollinger-Ellison syndrome have received this medicine for up to 1 year.

Child dose

Safety in children has not been established.

Precautions

This medication should not be used in patients with an allergic reaction or hypersensitivity to certain ingredients. In particular, it should be avoided in patients hypersensitive to penicillin or macrolide antibiotics, pregnant or nursing women, and patients taking certain antivirals (atazanavir, rilpivirine). Patients with liver function issues, elderly patients, those with a history of drug allergies, and those sensitive to the dye contained in this medicine (Yellow No. 4) should use it cautiously. While taking this medication, various side effects such as skin rash, itching, blood disorders, liver dysfunction, heart issues, gastrointestinal abnormalities, neurological symptoms, respiratory problems, muscle and joint pain, skin abnormalities, visual and auditory disturbances, and urinary issues may occur, so any abnormal symptoms should be promptly consulted with healthcare personnel. This medication suppresses gastric acid secretion, and long-term use may increase the risk of gastrointestinal infections and the risk of fractures associated with osteoporosis. Therefore, regular examinations are necessary during prolonged use. Moreover, this medication can interact with other drugs; caution is required when used in combination with warfarin, methotrexate, certain antibiotics, and antivirals, and you must inform healthcare personnel about any other medications being taken. Pregnant or nursing women should not use this medication, and elderly patients should exercise caution as they may have a higher risk of side effects due to decreased liver function. Do not chew or crush this medication; swallow the tablet whole and keep it out of reach of children. In the case of overdose, there is no specific antidote, so treatment should be symptomatic and supportive, and immediate medical assistance should be sought if abnormal symptoms appear.

Side effects

Rash, urticaria, itching, erythrocytopenia, leukopenia, leukocytosis, eosinophilia, neutrophilia, lymphocytopenia, anemia, purpura, lymphadenopathy, hypochromic anemia, pancytopenia, agranulocytosis, thrombocytopenia, hemolytic anemia, increased ALT, increased AST, increased ALP, increased γ-GTP, increased LDH, increased total bilirubin, fulminant hepatitis, liver dysfunction, jaundice, hypertension, myocardial infarction, abnormal ECG, migraine, syncope, angina pectoris, block of conduction, palpitations, bradycardia, tachycardia, pulmonary embolism, supraventricular tachycardia, thrombophlebitis, vasodilation, prolonged QTc, ventricular tachycardia, diarrhea, constipation, abdominal pain, abdominal distension, dyspepsia, belching, nausea, rectal bleeding, bloody stool, anorexia, cholelithiasis, oral ulcer, dysphagia, gingivitis, cholecystitis, increased appetite, abnormal stools, colitis, esophagitis, glossitis, pancreatitis, proctitis, thirst, vomiting, lower abdominal pain, gastric body, gastritis, stomatitis, dysgeusia, hemorrhagic diarrhea, cholangitis, duodenitis, gastrointestinal bleeding, hepatic encephalopathy, hepatitis, liver cancer, hepatic steatosis, salivary gland enlargement, thirst, headache, insomnia, anxiety, dizziness, convulsions, abnormal dreams, decreased libido, neuropathy, sensory disturbances, tremors, asthenia, neuroexcitability, drowsiness, vertigo, depression, restlessness, amnesia, confusion, extrapyramidal syndrome, hypervolemia, weakness in upper and lower extremities, impaired perception, decreased grip strength, language confusion, staggering, delirium, disorientation, hypersomnia, cough, pharyngitis, rhinitis, dyspnea, asthma, epistaxis, laryngitis, hiccups, hyperventilation, bronchitis, sinusitis, apnea, respiratory depression, interstitial pneumonia, myalgia, low back pain, arthritis, leg cramps, bone pain, arthropathy, bursitis, hypertonia, neuralgia, single contraction, sweating, alopecia, skin dryness, herpes zoster, psoriasis, skin color change, toxic epidermal necrolysis, mucous membrane syndrome, erythema multiforme, cataract, amblyopia, glaucoma, dry eyes, abnormal vision, tinnitus, otitis media, corneal opacity, blurred vision, double vision, hearing loss, eye pain, retinal degeneration, strabismus, proteinuria, cystitis, frequent urination, dysmenorrhea, dysuria, nephrolithiasis, uterine bleeding, polyuria, gynecomastia, hematuria, erectile dysfunction, vaginal discharge, menorrhagia, orchitis, urinary incontinence, interstitial nephritis, edema, increased total cholesterol, increased triglycerides, increased BUN, increased serum thyroid-stimulating hormone, chest pain, chills, fever, urinary tract infection, erythema, fatigue, weight gain, visual disturbances, anorexia, neck stiffness, phototoxic reaction, hangover effect, weight loss, gout, anaphylactic reaction, shock, hepatitis, jaundice, hepatic encephalopathy, sudden death, coma, hyperammonemia, rhabdomyolysis, delirium, angioedema, hypomagnesemia, thrombocytopenia, neutropenia, agranulocytosis, hemolytic anemia, pancytopenia, vesicular skin rash, urticarial skin rash, systemic allergic reaction, arthralgia, interstitial nephritis, gynecomastia, interstitial pneumonia, increased thyroid-stimulating hormone, lupus erythematosus, systemic lupus erythematosus, acute interstitial nephritis, halitosis, dry mouth, chest tightness, allergic reaction, hypertriglyceridemia, hypercholesterolemia, palpitations, increased intraocular pressure, urinary tract infection

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air and moisture, so it should be stored in a tightly closed container. The storage temperature should be maintained at room temperature between 1 degree and 30 degrees Celsius to preserve the drug's efficacy and safety for a prolonged period.

Appearance and packaging

Appearance

Pale yellow, round, enteric-coated tablet

Package unit

28 tablets (14 tablets/AluAlu packaging x 2)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.